Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells.
作者信息
Klinger Rebecca, Bursac Nenad
出版信息
IEEE Eng Med Biol Mag. 2008 Jan-Feb;27(1):72-80. doi: 10.1109/MEMB.2007.913849.
Abstract
摘要
相似文献
1
Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells.
IEEE Eng Med Biol Mag. 2008 Jan-Feb;27(1):72-80. doi: 10.1109/MEMB.2007.913849.
2
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.
J Mol Cell Cardiol. 2007 Apr;42(4):746-59. doi: 10.1016/j.yjmcc.2006.12.008. Epub 2006 Dec 23.
3
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
Biochem Biophys Res Commun. 2007 Aug 10;359(4):877-83. doi: 10.1016/j.bbrc.2007.05.216. Epub 2007 Jun 11.
4
In vitro assays for neural stem cell differentiation.
Methods Mol Biol. 2002;198:149-55. doi: 10.1385/1-59259-186-8:149.
5
c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes.
Clin Transl Sci. 2009 Feb;2(1):26-32. doi: 10.1111/j.1752-8062.2008.00089.x.
6
Methods to study the proliferation and differentiation of cardiac side population (CSP) cells.
Methods Mol Biol. 2013;1036:95-106. doi: 10.1007/978-1-62703-511-8_9.
7
Cooperation of biological and mechanical signals in cardiac progenitor cell differentiation.
Adv Mater. 2011 Jan 25;23(4):514-8. doi: 10.1002/adma.201003479. Epub 2010 Nov 12.
8
Isolation and expansion of adult cardiac stem cells from human and murine heart.
Circ Res. 2004 Oct 29;95(9):911-21. doi: 10.1161/01.RES.0000147315.71699.51. Epub 2004 Oct 7.
9
Identification of stem cells after transplantation.
Methods Mol Biol. 2013;1036:89-94. doi: 10.1007/978-1-62703-511-8_8.
10
In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.
Stem Cell Rev Rep. 2011 Jun;7(2):364-80. doi: 10.1007/s12015-010-9200-z.
引用本文的文献
1
Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy.
Nat Commun. 2022 Feb 2;13(1):620. doi: 10.1038/s41467-022-28251-6.
2
Microheterogeneity-induced conduction slowing and wavefront collisions govern macroscopic conduction behavior: A computational and experimental study.
PLoS Comput Biol. 2018 Jul 16;14(7):e1006276. doi: 10.1371/journal.pcbi.1006276. eCollection 2018 Jul.
3
Generation and customization of biosynthetic excitable tissues for electrophysiological studies and cell-based therapies.
Nat Protoc. 2018 May;13(5):927-945. doi: 10.1038/nprot.2018.016. Epub 2018 Apr 5.
4
Engineering prokaryotic channels for control of mammalian tissue excitability.
Nat Commun. 2016 Oct 18;7:13132. doi: 10.1038/ncomms13132.
5
Quantifying electrical interactions between cardiomyocytes and other cells in micropatterned cell pairs.
Methods Mol Biol. 2014;1181:249-62. doi: 10.1007/978-1-4939-1047-2_21.
6
Laser patterning for the study of MSC cardiogenic differentiation at the single-cell level.
Light Sci Appl. 2013;2. doi: 10.1038/lsa.2013.24.
7
Spatial profiles of electrical mismatch determine vulnerability to conduction failure across a host-donor cell interface.
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1200-7. doi: 10.1161/CIRCEP.113.001050. Epub 2013 Nov 14.
8
Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues.
PLoS One. 2013 Jun 13;8(6):e65963. doi: 10.1371/journal.pone.0065963. Print 2013.
9
Genetic engineering of somatic cells to study and improve cardiac function.
Europace. 2012 Nov;14 Suppl 5(Suppl 5):v40-v49. doi: 10.1093/europace/eus269.
10
Quantitatively analyzing the protective effect of mesenchymal stem cells on cardiomyocytes in single-cell biochips.
Biotechnol Lett. 2012 Jul;34(7):1385-91. doi: 10.1007/s10529-012-0906-7. Epub 2012 Mar 17.
本文引用的文献
1
Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts.
Circulation. 2007 Oct 30;116(18):2018-28. doi: 10.1161/CIRCULATIONAHA.107.712935. Epub 2007 Oct 15.
2
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart.
Circulation. 2007 Aug 21;116(8):917-27. doi: 10.1161/CIRCULATIONAHA.106.668178. Epub 2007 Aug 7.
3
Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells.
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3877-82. doi: 10.1073/pnas.0700416104. Epub 2007 Feb 26.
4
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.
J Mol Cell Cardiol. 2007 Apr;42(4):746-59. doi: 10.1016/j.yjmcc.2006.12.008. Epub 2006 Dec 23.
5
Genetically selected stem cells from human adipose tissue express cardiac markers.
Biochem Biophys Res Commun. 2007 Feb 16;353(3):665-71. doi: 10.1016/j.bbrc.2006.12.103. Epub 2006 Dec 22.
6
Theoretical impact of the injection of material into the myocardium: a finite element model simulation.
Circulation. 2006 Dec 12;114(24):2627-35. doi: 10.1161/CIRCULATIONAHA.106.657270. Epub 2006 Nov 27.
7
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.
J Exp Med. 2006 Oct 2;203(10):2315-27. doi: 10.1084/jem.20061469. Epub 2006 Sep 5.
8
Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells.
Med Biol Eng Comput. 2006 Jul;44(7):537-42. doi: 10.1007/s11517-006-0059-8. Epub 2006 Apr 20.
9
Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.
Circulation. 2006 Jul 25;114(4):353-8. doi: 10.1161/CIRCULATIONAHA.106.639385.
10
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .
Circulation. 2006 Jul 25;114(4):339-52. doi: 10.1161/CIRCULATIONAHA.105.590653.
Zotero 插件